Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Cell Metabolism|April 6, 2017
Pancreas and Not Gut Mediates the GLP-1-Induced Glucoincretin EffectJoel F Habener, Violeta StanojevicBest Practice & Research. Clinical Endocrinology & Metabolism|December 24, 2015
Evolving function and potential of pancreatic alpha cellsVioleta Stanojevic, Joel F HabenerTrends in Endocrinology and Metabolism: TEM|December 25, 2012
Alpha cells come of ageJoel F Habener, Violeta StanojevicIslets|August 1, 2012
α-cell role in β-cell generation and regenerationJoel F Habener, Violeta StanojevicRegulatory Peptides|January 25, 2011
GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytesEva Tomas, Violeta Stanojevic, Joel F HabenerEndocrinology|March 6, 2004
Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300Violeta Stanojevic, Joel F Habener, Melissa K ThomasRegulatory Peptides|May 10, 2011
GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese miceEva Tomas, Jenna A Wood, Violeta Stanojevic, et al.The Journal of Endocrinology|March 15, 2012
GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicityZhengu Liu, Violeta Stanojevic, Luke J Brindamour, et al.Biochemical and Biophysical Research Communications|February 5, 2008
Cytosolic adenylate kinases regulate K-ATP channel activity in human beta-cellsVioleta Stanojevic, Joel F Habener, George G Holz, et al.Diabetes|April 11, 2015
GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese MiceEva Tomas, Violeta Stanojevic, Karen McManus, et al.Pageof 6